Blaze Bioscience announces FDA has granted Fast Track Designation to BLZ-100 (tozuleristide) for pediatric central nervous system tumors

tozuleristide (BLZ-100) - Blaze Bioscience, Fred Hutchinson Cancer Research Center

Apr 7, 2020